Iguana Healthcare Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-150,000
Closed -$1.9M 79
2017
Q1
$1.9M Buy
150,000
+90,000
+150% +$1.07M 0.94% 34
2016
Q4
$613K Sell
60,000
-390,000
-87% -$4.45M 0.37% 54
2016
Q3
$5.93M Buy
450,000
+200,000
+80% +$2.67M 1.06% 34
2016
Q2
$3.17M Hold
250,000
1.29% 27
2016
Q1
$3.3M Sell
250,000
-25,000
-9% -$328K 1.21% 26
2015
Q4
$4.23M Buy
275,000
+15,000
+6% +$215K 1.39% 18
2015
Q3
$3.22M Buy
260,000
+10,000
+4% +$138K 1.27% 26
2015
Q2
$3.42M Buy
+250,000
New +$3.38M 1.08% 31

Other funds holding MDRX

Iguana Healthcare Management's MDRX Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2017, closing a stake of 150,000 shares — an estimated $1.9M sold.

Iguana Healthcare Management first reported a position in MDRX in Q2 2015 and held it in 8 quarters. The position peaked at $5.93M in Q3 2016. 232 funds tracked by Wall St. Rank hold MDRX as of Q2 2017.

  • Iguana Healthcare Management reported no remaining Veradigm Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 150,000 Veradigm Inc. Common Stock shares in Q2 2017, an estimated $1.9M.
  • Iguana Healthcare Management first reported a position in Veradigm Inc. Common Stock in Q2 2015 and held it in 8 quarters.
  • Iguana Healthcare Management's Veradigm Inc. Common Stock position peaked at $5.93M in Q3 2016.
  • 232 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.